Poor countries pay the cost after Covax puts all its eggs in one basket

India’s top vaccine maker has been unable to send shots overseas since April, but its problems began long before

09 June 2021 - 20:52 By Chris Kay and PR Sanjai

Around the world, from Bangladesh to Nepal to Rwanda, vulnerable hotspots have been grappling with stalled Covid-19 vaccination programmes as they run out of doses. Many of those shortages can be traced back to a single company: The Serum Institute of India.

The world’s largest vaccine maker, Serum was last year named a top supplier of Covid shots to Covax, the World Health Organisation-backed initiative aimed at securing an equitable global rollout. But the Indian company has been dogged by setbacks, from a ban on exports to a factory fire, that have hampered its ability to fill orders...

This article is free to read if you register or sign in.

If you have already registered or subscribed, please sign in to continue.

Questions or problems? Email helpdesk@timeslive.co.za or call 0860 52 52 00.